CJC-1295, Hexarelin 10mg (Blend)

68.00 USD

Availability: In stock

FREE Shipping for orders over $200 (USA Only)

$15.00 Flat Rate Shipping Worldwide (Most Countries) 

*Includes one 30mL Bacteriostatic Water with orders over $300.00

$68.00
  • Buy 5 for $65.00 each and save 5%
  • Buy 10 for $63.00 each and save 8%
CJC-1295 5mg, Hexarelin 5mg (10mg Total Blend)

CJC-1295, Hexarelin 10mg (Blend)

Product Usage: THIS PRODUCT IS INTENDED AS A RESEARCH CHEMICAL ONLY. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabled as a drug, food or cosmetic.

Hexarelin,which is a potent stimulator of the growth hormone secretagogue receptor. When combined with CJC-1295, a growth hormone releasing hormone receptor agonist, the two GH stimulants boost both baseline and peak levels of GH in animal models.

Both peptides have positive effects on cardiac (heart) muscle. Hexarelin, in particular, has been heavily investigated for its ability to protect heart cells from damage during ischemic injury (e.g. heart attack). There is good reason to believe that a combination of both peptides could improve outcomes during acute coronary events, aid recovery following myocardial injury, and even prevent cardiac injury in the first p[1]–[3].

Hexarelin and CJC-1295 both potentiate fat metabolism and have been linked to improved measures of insulin resistance. Reduction in adipose tissue mass is linked to decreased systemic inflammation and improvements in everything from type 2 diabetes to the risk of developing cancer[4]. Both peptides are also being investigated for their ability to protect muscle from the effects of chemotherapy[5], [6].

About The Author

Research by L. Edmiston, M.D. for Peptide Sciences. L. Edmiston holds an M.D. from Case Western Reserve University School of Medicine and a B.S. in molecular biology.

Resources

  • [1] X. Zhang, L. Qu, L. Chen, and C. Chen, “Improvement of cardiomyocyte function by in vivo hexarelin treatment in streptozotocin-induced diabetic rats,” Physiol. Rep., vol. 6, no. 4, 2018. [PubMed]
  • [2] J. Huang, Y. Li, J. Zhang, Y. Liu, and Q. Lu, “The Growth Hormone Secretagogue Hexarelin Protects Rat Cardiomyocytes From in vivo Ischemia/Reperfusion Injury Through Interleukin-1 Signaling Pathway,” Int. Heart. J., vol. 58, no. 2, pp. 257–263, Apr. 2017. [PubMed]
  • [3] Y. Ma, L. Zhang, J. N. Edwards, B. S. Launikonis, and C. Chen, “Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium,” PloS One, vol. 7, no. 4, p. e35265, 2012.
  • [4] R. Mosa et al., “Hexarelin, a Growth Hormone Secretagogue, Improves Lipid Metabolic Aberrations in Nonobese Insulin-Resistant Male MKR Mice,” Endocrinology, vol. 158, no. 10, pp. 3174–3187, 01 2017. [PubMed]
  • [5] E. Conte et al., “Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia,” J. Cachexia Sarcopenia Muscle, vol. 8, no. 3, pp. 386–404, Jun. 2017. [PubMed]
  • [6] G. Sirago et al., “Growth hormone secretagogues hexarelin and JMV2894 protect skeletal muscle from mitochondrial damages in a rat model of cisplatin-induced cachexia,” Sci. Rep., vol. 7, Oct. 2017. [Nature]